Bristol Myers Squibb Announces Data from EXPLORER-LTE Demonstrating Sustained Improvements in Clinic - PharmiWeb.com
4/3/2022 12:00:00 AM3 years 1 month ago
by Businesswire
by Businesswire
Treatment with mavacamten showed sustained improvement in left ventricular outflow tract (LVOT) gradients, New York Heart Association (NYHA) Class and N-terminal pro brain natriuretic peptide (NT-proBNP) levelsAt 48 and 84 Weeks, Mavacamten safety was consist…
Treatment with mavacamten showed sustained improvement in left ventricular outflow tract (LVOT) gradients, New York Heart Association (NYHA) Class and N-terminal pro brain natriuretic peptide (NT-pro… [+10230 chars]
full article...